Lyell Immunopharma, Inc.
7 clinical trials · Sponsor
◉ Watch Lyell Immunopharma, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy (NCT07188558) | Lyell Immunopharma, Inc. | 2026-01-12 |
| A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) (NCT06153095) | Lyell Immunopharma, Inc. | 2024-02-15 |
| A Biomarker Screening Protocol for Participants With Solid Tumors (NCT05891197) | Lyell Immunopharma, Inc. | 2023-05-19 |
| Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma (NCT05826535) | Lyell Immunopharma, Inc. | 2023-05-09 |
| A Study to Investigate LYL845 in Adults With Solid Tumors (NCT05573035) | Lyell Immunopharma, Inc. | 2022-12-19 |
| LYL273 for Patients With Relapsed or Refractory mCRC (NCT05319314) | Lyell Immunopharma, Inc. | 2022-08-01 |
| A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451) | Lyell Immunopharma, Inc. | 2022-03-29 |
Track Lyell Immunopharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.